ImmuCell Corporation ICCC
NASDAQ · United States · Health Technology
$9.75+0.15 (+1.56%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
ImmuCell Corp (ICCC) reports 11.5% sales growth and a 19% U.S. market share, while investing $8 million to triple manufacturing capacity.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.